Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth
暂无分享,去创建一个
[1] Zichao Guo,et al. Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer. , 2022, Clinical immunology.
[2] Ihor O. Arkhypov,et al. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling , 2022, Journal for ImmunoTherapy of Cancer.
[3] Han Liu,et al. Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study , 2022, Hepatology International.
[4] Tao Li,et al. Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy , 2022, Cells.
[5] W. Linehan,et al. Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma , 2022, Journal of Experimental & Clinical Cancer Research.
[6] David Killock. HSP90 inhibition improves GIST survival , 2022, Nature Reviews Clinical Oncology.
[7] Qiushi Ren,et al. A Hybrid Imaging Platform(CT/PET/FMI) for Evaluating Tumor Necrosis and Apoptosis in Real-Time , 2022, Frontiers in Oncology.
[8] R. Sýkora,et al. Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis. , 2022, The American journal of pathology.
[9] A. Zarbock,et al. The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction , 2022, Cells.
[10] S. Eccles,et al. HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells , 2022, BMC cancer.
[11] Ming-ze Ma,et al. HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC , 2022, Journal of Cancer.
[12] J. Seo,et al. A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response , 2022, Oncogene.
[13] T. Du,et al. Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer , 2022, International journal of molecular sciences.
[14] G. Kroemer,et al. Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade , 2022, Oncoimmunology.
[15] Y. Fujii,et al. HSP90 inhibition overcomes resistance to molecular targeted therapy in BRAFV600E mutant high-grade glioma. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] G. Mills,et al. Anti-tumor Activity of a Mitochondrial Targeted HSP90 Inhibitor in Gliomas. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] M. Kumar,et al. SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer , 2022, Cell reports. Medicine.
[18] Zejun Lu,et al. HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6‐mediated CD147 polyubiquitination , 2022, Cancer science.
[19] Nicolò Riggi,et al. Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis , 2022, Life Science Alliance.
[20] L. Conti,et al. Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy , 2021, Oncoimmunology.
[21] Y. Seimbille,et al. In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors , 2021, Contrast media & molecular imaging.
[22] S. Raimondo,et al. Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways , 2021, International journal of molecular sciences.
[23] N. Abu,et al. Extracellular Vesicles and DAMPs in Cancer: A Mini-Review , 2021, Frontiers in Immunology.
[24] Tejaswini Appidi,et al. The role played by bacterial infections in the onset and metastasis of cancer , 2021, Current research in microbial sciences.
[25] Xueqin Li,et al. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling , 2021, Cell Death & Disease.
[26] W. Fiedler,et al. High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells , 2021, Frontiers in Immunology.
[27] Wei Li,et al. Tumor necrosis: A synergistic consequence of metabolic stress and inflammation , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.
[28] J. O’Sullivan,et al. Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett’s and Oesophageal Adenocarcinoma Disease Progression , 2021, Cancers.
[29] Wenhui Zhang,et al. Exosomal HMGB1 derived from hypoxia‐conditioned bone marrow mesenchymal stem cells increases angiogenesis via the JNK/HIF‐1α pathway , 2021, FEBS open bio.
[30] Xiaolei Shi,et al. Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21 , 2021, Aging.
[31] K. Xiong,et al. Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective , 2021, Frontiers in Cell and Developmental Biology.
[32] Bo Chen,et al. Prognostic values and immune suppression of the S100A family in pancreatic cancer , 2021, Journal of cellular and molecular medicine.
[33] Shih-Yi Lin,et al. Exosomal HMGB1 Promoted Cancer Malignancy , 2021, Cancers.
[34] J. Zang,et al. Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma , 2021, Frontiers in Cell and Developmental Biology.
[35] G. Chiang,et al. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis. , 2021, Neuroimaging clinics of North America.
[36] James O. Jones,et al. Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth , 2021, Nature Communications.
[37] W. Han,et al. S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell–cell interactions with adjacent breast cancer cells , 2018, Scientific Reports.
[38] Y. Park,et al. HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer. , 2021, American journal of cancer research.
[39] Asma Ahmed,et al. Targeting immunogenic cell death in cancer , 2020, Molecular oncology.
[40] A. Engelbrecht,et al. Serum amyloid A and inflammasome activation: A link to breast cancer progression? , 2020, Cytokine & growth factor reviews.
[41] Xiaohong Liao,et al. HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis. , 2020, Neoplasma.
[42] S. Tavazoie,et al. Tumoural activation of TLR3–SLIT2 axis in endothelium drives metastasis , 2020, Nature.
[43] D. Colangelo,et al. Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding , 2020, PLoS pathogens.
[44] P. Tsai,et al. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis , 2020, Scientific Reports.
[45] Nan Li,et al. Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression , 2020, Cell Communication and Signaling.
[46] J. Waldron,et al. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. , 2020, Cell reports.
[47] P. Li,et al. Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma , 2020, BMC Cancer.
[48] Y. Gan,et al. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27 , 2020, Aging.
[49] Y. Ni,et al. Discovery of necrosis avidity of rhein and its applications in necrosis imaging , 2020, Journal of drug targeting.
[50] Zhijiao Duan,et al. Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells , 2020, Journal of Cancer.
[51] F. Di Virgilio,et al. Purinergic signalling, DAMPs and inflammation. , 2020, American journal of physiology. Cell physiology.
[52] Y. Ni,et al. Rhein‐based necrosis‐avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy , 2019, Magnetic resonance in medicine.
[53] Kartik Gupta,et al. Necroptosis in the Pathophysiology of Disease. , 2019, The American journal of pathology.
[54] Yan Yan,et al. Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer , 2019, Molecular Cancer Therapeutics.
[55] Wenjin Liang,et al. HSP27 promotes epithelial-mesenchymal transition through activation of the β-catenin/MMP3 pathway in pancreatic ductal adenocarcinoma cells , 2019, Translational cancer research.
[56] Panli Li,et al. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis , 2019, Molecular Imaging and Biology.
[57] M. Lotze,et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth , 2019, Oncoimmunology.
[58] I. Harting,et al. Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study , 2019, Neurology.
[59] Nicole M. Chapman,et al. Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression. , 2019, Cancer research.
[60] S. Bornstein,et al. The pathological features of regulated necrosis , 2019, The Journal of pathology.
[61] Y. Ni,et al. Updated developments on molecular imaging and therapeutic strategies directed against necrosis , 2019, Acta pharmaceutica Sinica. B.
[62] M. Borad,et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. , 2019, Nature.
[63] Hongbing Ma,et al. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy , 2019, Cell Death & Disease.
[64] Haitao Zhu,et al. Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1 , 2019, EBioMedicine.
[65] Soohyun Kim,et al. Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer , 2019, Oncotarget.
[66] R. Oehler,et al. Circulating Biomarkers of Cell Death. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[67] Z. Környei,et al. Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer , 2018, British Journal of Cancer.
[68] Guihua Chen,et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion , 2018, Journal of Immunotherapy for Cancer.
[69] M. Berger,et al. Tissue necrosis and its role in cancer progression , 2018, Oncogene.
[70] Y. Ni,et al. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis. , 2018, Analytical chemistry.
[71] Thuy-vi Nguyen,et al. Liquefaction of the Brain following Stroke Shares a Similar Molecular and Morphological Profile with Atherosclerosis and Mediates Secondary Neurodegeneration in an Osteopontin-Dependent Mechanism , 2018, eNeuro.
[72] Yong Jiang,et al. Hsp27 regulates epithelial mesenchymal transition, metastasis and proliferation in colorectal carcinoma. , 2018, Oncology letters.
[73] D. Sharma,et al. Necroptosis: a regulated inflammatory mode of cell death , 2018, Journal of Neuroinflammation.
[74] M. Mehrabi,et al. Active Role of the Necrotic Zone in Desensitization of Hypoxic Macrophages and Regulation of CSC-Fate: A hypothesis , 2018, Front. Oncol..
[75] M. Lotze,et al. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy. , 2018, The Journal of surgical research.
[76] T. Vogl,et al. Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy , 2018, Front. Immunol..
[77] Wei Chen,et al. HSP27 associates with epithelial–mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma , 2018, Journal of cellular and molecular medicine.
[78] Hyun Min Jeon,et al. Regulation of Tumor Progression by Programmed Necrosis , 2018, Oxidative medicine and cellular longevity.
[79] Frank Höppner,et al. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4 , 2016, PloS one.
[80] K. Nael,et al. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma. , 2018, AJR. American journal of roentgenology.
[81] S. Lipton,et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.
[82] J. Xu,et al. Downregulation of Calcium-Binding Protein S100A9 Inhibits Hypopharyngeal Cancer Cell Proliferation and Invasion Ability Through Inactivation of NF-κB Signaling. , 2017, Oncology research.
[83] A. Pandiella,et al. Neutrophils in cancer: prognostic role and therapeutic strategies , 2017, Molecular Cancer.
[84] T. Espevik,et al. Surface TLR 3 expression in metastatic IECs 15410 , 2017 .
[85] B. Nabet,et al. Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer , 2017, Cell.
[86] A. Kulkarni,et al. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma , 2017, Molecular Cancer.
[87] Xiao Wang,et al. Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. , 2017, Biochimica et biophysica acta. General subjects.
[88] J. Pavelić,et al. Toll‐like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF , 2017, Molecular carcinogenesis.
[89] Christopher J. Mitchell,et al. Toward the human cellular microRNAome , 2017, bioRxiv.
[90] A. Dingemans,et al. Heat shock protein antagonists in early stage clinical trials for NSCLC , 2017, Expert opinion on investigational drugs.
[91] Qibing Mei,et al. Heat Shock Proteins and Cancer. , 2017, Trends in pharmacological sciences.
[92] Y. Yamamoto,et al. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis , 2017, Oncogene.
[93] R. Huddart,et al. The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004) , 2017, British Journal of Cancer.
[94] Y. Ni,et al. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium. , 2017, Analytical chemistry.
[95] E. Latz,et al. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins , 2016, Cellular & Molecular Immunology.
[96] S. Zeerleder,et al. Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation , 2016, Cell Death & Disease.
[97] D. Zagzag,et al. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells , 2016, Oncotarget.
[98] Xuetao Cao,et al. Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. , 2016, Cancer cell.
[99] L. French,et al. Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages , 2016, Scientific Reports.
[100] W. ElShamy,et al. Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors? , 2016, Stem cells international.
[101] Hongbo Wang,et al. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. , 2016, Oncology reports.
[102] Rihua Zhang,et al. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer , 2016, Tumor Biology.
[103] Karl Kashofer,et al. Inferring expressed genes by whole-genome sequencing of plasma DNA , 2016, Nature Genetics.
[104] R. Muschel,et al. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells , 2016, Oncogene.
[105] M. Lotze,et al. Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment , 2016, Transfusion Medicine and Hemotherapy.
[106] Jens Pietzsch,et al. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells , 2016, Journal of cellular and molecular medicine.
[107] Da Li,et al. Effects of receptor for advanced glycation endproducts on microvessel formation in endometrial cancer , 2016, BMC Cancer.
[108] Young Hun Kim,et al. N-linked glycosylation plays a crucial role in the secretion of HMGB1 , 2016, Journal of Cell Science.
[109] P. Pickkers,et al. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients , 2016, Intensive Care Medicine.
[110] J. Seuntjens,et al. The Role of HMGB1 in Radioresistance of Bladder Cancer , 2015, Molecular Cancer Therapeutics.
[111] J. Mayerson,et al. Osteosarcoma: A Meta-Analysis and Review of the Literature. , 2015, American journal of orthopedics.
[112] M. Lotze,et al. DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’ , 2015, Ageing Research Reviews.
[113] G. Mælandsmo,et al. Metabolic reprogramming supports the invasive phenotype in malignant melanoma. , 2015, Cancer letters.
[114] Yi-Wen Chen,et al. Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production , 2015, Oncotarget.
[115] P. Delvenne,et al. HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells , 2015, International journal of cancer.
[116] M. Lotze,et al. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. , 2015, Journal of hepatology.
[117] Jingyuan Fang,et al. Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma , 2015, Journal of cellular and molecular medicine.
[118] R. Wu,et al. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. , 2015, Experimental cell research.
[119] S. Pastorino,et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression , 2015, Cell Death and Disease.
[120] Ling Zhou,et al. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer , 2015, Journal of experimental & clinical cancer research : CR.
[121] Xianjun Zhu,et al. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma , 2015, Oncotarget.
[122] S. Ghavami,et al. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells. , 2015, Thyroid : official journal of the American Thyroid Association.
[123] Hai-hua Luo,et al. AB044. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation , 2015, American journal of cancer research.
[124] Zhuo Zhang,et al. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[125] M. Gleave,et al. Hsp27 regulates EGF/β‐catenin mediated epithelial to mesenchymal transition in prostate cancer , 2015, International journal of cancer.
[126] Michael C. Ostrowski,et al. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. , 2015, Cancer research.
[127] V. Wong,et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.
[128] Xiao-hou Wu,et al. Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3 , 2015, Medical Oncology.
[129] F. Watt,et al. Innate sensing of microbial products promotes wound-induced skin cancer , 2015, Nature Communications.
[130] T. Zima,et al. RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets? , 2015, Neoplasma.
[131] Jinyong Peng,et al. Novel Role of Resveratrol: Suppression of High-Mobility Group Protein Box 1 Nucleocytoplasmic Translocation by the Upregulation of Sirtuin 1 in Sepsis-Induced Liver Injury , 2014, Shock.
[132] K. Tracey,et al. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. , 2014, Cancer research.
[133] W. Neuhofer,et al. NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells , 2014, Front. Physiol..
[134] D. Tang,et al. Release and activity of histone in diseases , 2014, Cell Death and Disease.
[135] P. Stattin,et al. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome. , 2014, European journal of cancer.
[136] Haichao Wang,et al. PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis , 2014, Nature Communications.
[137] Minho Chae,et al. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid‐derived suppressor cells via TLR2‐dependent STAT3 activation , 2014, European journal of immunology.
[138] A. Ochiai,et al. High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro‐inflammatory cytokines in peritoneal fibroblasts , 2014, Pathology international.
[139] A. Horii,et al. S100A4 is frequently overexpressed in lung cancer cells and promotes cell growth and cell motility. , 2014, Biochemical and biophysical research communications.
[140] K. Tracey,et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. , 2014, Gastroenterology.
[141] Tianshu Yang,et al. High‐mobility group box‐1 and its role in angiogenesis , 2014, Journal of leukocyte biology.
[142] T. Clancy,et al. Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties. , 2014, Cancer letters.
[143] K. Syrigos,et al. Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review , 2014, SpringerPlus.
[144] F. Di Virgilio,et al. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment , 2014, Cell Death and Disease.
[145] Wei Li,et al. Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging , 2014, Genes & development.
[146] I. Pedrosa,et al. Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. , 2014, Clinical genitourinary cancer.
[147] Haichao Wang,et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics , 2014, Oncogene.
[148] P. Vandenabeele,et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways , 2014, Nature Reviews Molecular Cell Biology.
[149] B. Viollet,et al. TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance. , 2013, Immunity.
[150] H. Nie,et al. Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7 , 2013, Clinical & developmental immunology.
[151] L. Antonioli,et al. Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.
[152] Laura Conti,et al. The noninflammatory role of high mobility group box 1/toll‐like receptor 2 axis in the self‐renewal of mammary cancer stem cells , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[153] Jianling Xie,et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.
[154] M. Gleave,et al. Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[155] Hong-Yang Wang,et al. p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release. , 2013, Journal of hepatology.
[156] F. Motoi,et al. The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion , 2013, Pancreas.
[157] Angelika Bierhaus,et al. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation‐associated liver carcinogenesis in mice , 2013, Hepatology.
[158] M. Lotze,et al. HMGB1 in Cancer: Good, Bad, or Both? , 2013, Clinical Cancer Research.
[159] M. Gleave,et al. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. , 2013, Cancer research.
[160] Q. Shi,et al. Correction: S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway , 2013, PLoS ONE.
[161] M. Markey,et al. Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. , 2013, Neuro-oncology.
[162] R. Donato,et al. Functions of S100 proteins. , 2012, Current molecular medicine.
[163] U. Andersson,et al. TLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis , 2012, The EMBO journal.
[164] K. Ishii,et al. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination , 2012, Front. Cell. Inf. Microbio..
[165] F. Chan,et al. Detection of necrosis by release of lactate dehydrogenase activity. , 2013, Methods in molecular biology.
[166] M. Tangney,et al. Bacteria and tumours: causative agents or opportunistic inhabitants? , 2013, Infectious Agents and Cancer.
[167] Qing Li,et al. Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling , 2012, The Journal of experimental medicine.
[168] M. Hance,et al. Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer* , 2012, The Journal of Biological Chemistry.
[169] A. Westendorf,et al. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. , 2012, International immunology.
[170] H. Yoshiyama,et al. Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 , 2012, Nature Immunology.
[171] A. Borkowski,et al. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3 , 2012, Nature Medicine.
[172] J. Fajkus,et al. HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction , 2012, Chromosoma.
[173] Kazuyuki Sugahara,et al. Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells* , 2012, The Journal of Biological Chemistry.
[174] D. Crawford,et al. Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. , 2012, Journal of Alzheimer's disease : JAD.
[175] G. Fritz. RAGE: a single receptor fits multiple ligands. , 2011, Trends in biochemical sciences.
[176] D. McMillan,et al. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. , 2011, Future oncology.
[177] D. Golenbock,et al. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. , 2011, Immunity.
[178] D. Jay,et al. Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion , 2011, PloS one.
[179] A. C. Könner,et al. Toll-like receptors: linking inflammation to metabolism , 2011, Trends in Endocrinology & Metabolism.
[180] K. Tracey,et al. Endogenous HMGB1 regulates autophagy , 2010, The Journal of cell biology.
[181] Samuel H. Wilson,et al. HMGB1: roles in base excision repair and related function. , 2010, Biochimica et biophysica acta.
[182] V. Gabai,et al. Mechanisms of tumor cell necrosis. , 2010, Current pharmaceutical design.
[183] J. Tschopp,et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.
[184] M. Omary,et al. Toward unraveling the complexity of simple epithelial keratins in human disease. , 2009, The Journal of clinical investigation.
[185] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[186] Haichao Wang,et al. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. , 2009, American journal of respiratory cell and molecular biology.
[187] F. Santilli,et al. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. , 2009, Current medicinal chemistry.
[188] R. Medzhitov,et al. Toll-like receptors and cancer , 2009, Nature Reviews Cancer.
[189] Hiroyuki Aburatani,et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.
[190] D. Foell,et al. Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.
[191] W. Nacken,et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.
[192] A. Enk,et al. RAGE signaling sustains inflammation and promotes tumor development , 2008, The Journal of experimental medicine.
[193] J. Sleeman,et al. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4 , 2008, Experimental dermatology.
[194] S. Fan,et al. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer , 2007, Acta Pharmacologica Sinica.
[195] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[196] V. Kuchroo,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.
[197] I. Ito,et al. Post-translational Methylation of High Mobility Group Box 1 (HMGB1) Causes Its Cytoplasmic Localization in Neutrophils* , 2007, Journal of Biological Chemistry.
[198] Haichao Wang,et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.
[199] L. Zitvogel,et al. Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.
[200] D. Pisetsky,et al. The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.
[201] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[202] James J. Lee,et al. Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response , 2006, Journal of leukocyte biology.
[203] M. Bours,et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.
[204] C. Coban,et al. A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.
[205] L. Whitesell,et al. Altered Hsp90 function in cancer: a unique therapeutic opportunity. , 2004, Molecular cancer therapeutics.
[206] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[207] G. Kramer,et al. Differentiation between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18 , 2004, Cancer Research.
[208] Tiziana Bonaldi,et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.
[209] R. Ye,et al. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.
[210] J Martin Brown,et al. Tumor Microenvironment and the Response to Anticancer Therapy , 2002, Cancer biology & therapy.
[211] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[212] A. Aguzzi,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.